DANIELI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 515
EU - Europa 352
AS - Asia 284
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.154
Nazione #
US - Stati Uniti d'America 507
CN - Cina 261
IE - Irlanda 142
FI - Finlandia 56
IT - Italia 56
UA - Ucraina 47
DE - Germania 29
SG - Singapore 12
FR - Francia 11
CA - Canada 8
SE - Svezia 5
GB - Regno Unito 3
IN - India 3
PK - Pakistan 3
JP - Giappone 2
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MU - Mauritius 1
NL - Olanda 1
Totale 1.154
Città #
Dublin 142
Chandler 124
Nanjing 81
Jacksonville 61
Beijing 56
New York 38
Boardman 30
Ashburn 24
Helsinki 23
Jiaxing 20
Changsha 19
Lawrence 19
Medford 19
Princeton 19
Wilmington 19
Nanchang 16
Shanghai 13
Hebei 12
Tianjin 11
Toronto 8
Forlì 7
Hangzhou 7
Pavia 7
Seattle 7
Shenyang 7
Singapore 7
Ann Arbor 6
Milan 5
Norwalk 5
Piscataway 5
Dearborn 4
Los Angeles 4
Guangzhou 3
Jinan 3
Lahore 3
Palermo 3
Taizhou 3
Verona 3
Dallas 2
Fairfax 2
Fairfield 2
Guardiagrele 2
Lodi 2
Padova 2
Potomac 2
Rome 2
Tokyo 2
Zhengzhou 2
Ascoli Piceno 1
Berlin 1
Bologna 1
Brisbane 1
Castelfrentano 1
Castelnuovo 1
Cinisello Balsamo 1
Cogorno 1
Kunming 1
Mountain View 1
Nuremberg 1
Olomouc 1
Penne 1
Perugia 1
Prineville 1
Rende 1
Vientiane 1
Washington 1
Woodbridge 1
Totale 882
Nome #
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 73
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 71
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 69
Impiego di cellule staminali mesenchimali in cardiologia. 69
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 68
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 68
Mesenchymal stem cell therapy for heart disease. 67
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 66
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 62
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 62
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 62
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 61
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 60
Paracrine mechanisms of mesenchymal stem cells in tissue repair 58
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 57
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 57
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 56
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 51
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 50
Totale 1.187
Categoria #
all - tutte 4.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202091 0 0 0 9 1 9 3 13 4 36 16 0
2020/202177 9 8 1 8 0 14 1 11 6 11 8 0
2021/202282 0 1 7 2 1 0 3 2 7 2 13 44
2022/2023372 43 37 0 12 40 28 0 25 166 2 11 8
2023/2024183 17 28 3 18 10 53 3 14 1 10 16 10
2024/202534 10 21 3 0 0 0 0 0 0 0 0 0
Totale 1.187